ProfileGDS5822 / ILMN_2838831
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 1% 0% 29% 4% 2% 2% 17% 3% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15.11
GSM1276600PDAC Late Ablation Control 20.80
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.429
GSM1276603PDAC Late Ablation 25.34
GSM1276604PDAC Late Ablation 33.42
GSM1303940PDAC Late Ablation_anti-CTLA4 15.12
GSM1303941PDAC Late Ablation_anti-CTLA4 29.817
GSM1303942PDAC Late Ablation_anti-CTLA4 32.53